Five Big Questions About COVID Vaccines for Kids
Some good news finally—finally—appears to be on the horizon for roughly 28 million of the United States’ youngest residents. On the heels of an advisory meeting convened yesterday, the FDA is likely on the cusp of green-lighting a kid-size dose of Pfizer’s COVID-19 vaccine for Americans ages 5 to 11, a move that’s been months in the making.